Traws Pharma, Inc. Increase (Decrease) in Contract with Customer, Liability
Traws Pharma, Inc. (TRAW) reported Increase (Decrease) in Contract with Customer, Liability of -$2.79 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2026-08-14
- Traws Pharma, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2025-12-31 was -$1.00K.
- Traws Pharma, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2025-09-30 was $1.00K.
- Traws Pharma, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2025-06-30 was -$2.73M.
- Traws Pharma, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2025-03-31 was -$57.00K.
- Traws Pharma, Inc. increase (decrease) in contract with customer, liability for fiscal 2025 was -$2.79M.
- Traws Pharma, Inc. increase (decrease) in contract with customer, liability for fiscal 2024 was -$226.00K.
- Traws Pharma, Inc. increase (decrease) in contract with customer, liability for fiscal 2023 was -$226.00K.
- Traws Pharma, Inc. increase (decrease) in contract with customer, liability for fiscal 2022 was -$226.00K.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 9 month | Increase (Decrease) in Contract with Customer, Liability 12 month |
|---|---|---|---|---|
| 2025-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $0.00 derived: sum of 2 quarters · filed 2026-04-15 | -$2.73M derived: sum of 3 quarters · filed 2026-08-14 | -$2.79M 10-K · filed 2026-04-15 |
| 2025-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$2.73M derived: sum of 2 quarters · filed 2026-08-14 | -$2.79M 10-Q · filed 2025-11-13 | -$2.85M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$2.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$2.79M 10-Q · filed 2026-08-14 | -$2.85M derived: sum of 3 quarters · filed 2026-08-14 | -$2.90M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$57.00K 10-Q · filed 2026-05-15 | -$113.00K derived: sum of 2 quarters · filed 2026-05-15 | -$170.00K derived: sum of 3 quarters · filed 2026-05-15 | -$227.00K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | -$56.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | -$113.00K derived: sum of 2 quarters · filed 2026-04-15 | -$170.00K derived: sum of 3 quarters · filed 2026-04-15 | -$226.00K 10-K · filed 2026-04-15 |
| 2024-09-30 | -$57.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$114.00K derived: sum of 2 quarters · filed 2025-11-13 | -$170.00K 10-Q · filed 2025-11-13 | -$226.00K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | -$57.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$113.00K 10-Q · filed 2025-08-14 | -$169.00K derived: sum of 3 quarters · filed 2025-08-14 | -$226.00K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | -$56.00K 10-Q · filed 2025-05-15 | -$112.00K derived: sum of 2 quarters · filed 2025-05-15 | -$169.00K derived: sum of 3 quarters · filed 2025-05-15 | -$226.00K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | -$56.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$113.00K derived: sum of 2 quarters · filed 2025-03-31 | -$170.00K derived: sum of 3 quarters · filed 2025-03-31 | -$226.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | -$57.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$114.00K derived: sum of 2 quarters · filed 2024-11-14 | -$170.00K 10-Q · filed 2024-11-14 | -$226.00K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | -$57.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-15 | -$113.00K 10-Q · filed 2024-08-15 | -$169.00K derived: sum of 3 quarters · filed 2024-08-15 | -$226.00K derived: sum of 4 quarters · filed 2024-08-15 |
| 2023-03-31 | -$56.00K 10-Q · filed 2024-05-15 | -$112.00K derived: sum of 2 quarters · filed 2024-05-15 | -$169.00K derived: sum of 3 quarters · filed 2024-05-15 | -$226.00K derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | -$56.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$113.00K derived: sum of 2 quarters · filed 2024-04-01 | -$170.00K derived: sum of 3 quarters · filed 2024-04-01 | -$226.00K 10-K · filed 2024-04-01 |
| 2022-09-30 | -$57.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$114.00K derived: sum of 2 quarters · filed 2023-11-14 | -$170.00K 10-Q · filed 2023-11-14 | -$226.00K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | -$57.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$113.00K 10-Q · filed 2023-08-14 | -$169.00K derived: sum of 3 quarters · filed 2023-08-14 | -$226.00K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | -$56.00K 10-Q · filed 2023-05-15 | -$112.00K derived: sum of 2 quarters · filed 2023-05-15 | -$169.00K derived: sum of 3 quarters · filed 2023-05-15 | -$226.00K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | -$56.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$113.00K derived: sum of 2 quarters · filed 2023-03-30 | -$170.00K derived: sum of 3 quarters · filed 2023-03-30 | -$226.00K 10-K · filed 2023-03-30 |
| 2021-09-30 | -$57.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$114.00K derived: sum of 2 quarters · filed 2022-11-14 | -$170.00K 10-Q · filed 2022-11-14 | -$227.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | -$57.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$113.00K 10-Q · filed 2022-08-15 | -$170.00K derived: sum of 3 quarters · filed 2022-08-15 | -$227.00K derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | -$56.00K 10-Q · filed 2022-05-13 | -$113.00K derived: sum of 2 quarters · filed 2022-05-13 | -$170.00K derived: sum of 3 quarters · filed 2022-05-13 | -$226.00K derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | -$57.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21 | -$114.00K derived: sum of 2 quarters · filed 2022-03-21 | -$170.00K derived: sum of 3 quarters · filed 2022-03-21 | -$226.00K 10-K · filed 2022-03-21 |
| 2020-09-30 | -$57.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$113.00K derived: sum of 2 quarters · filed 2021-11-15 | -$169.00K 10-Q · filed 2021-11-15 | -$226.00K derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | -$56.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | -$112.00K 10-Q · filed 2021-08-16 | -$169.00K derived: sum of 3 quarters · filed 2021-08-16 | -$226.00K derived: sum of 4 quarters · filed 2021-08-16 |
| 2020-03-31 | -$56.00K 10-Q · filed 2021-05-17 | -$113.00K derived: sum of 2 quarters · filed 2021-05-17 | -$170.00K derived: sum of 3 quarters · filed 2021-05-17 | -$226.00K derived: sum of 4 quarters · filed 2021-05-17 |
| 2019-12-31 | -$57.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | -$114.00K derived: sum of 2 quarters · filed 2021-03-18 | -$170.00K derived: sum of 3 quarters · filed 2021-03-18 | -$227.00K 10-K · filed 2021-03-18 |
| 2019-09-30 | -$57.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | -$113.00K derived: sum of 2 quarters · filed 2020-11-16 | -$170.00K 10-Q · filed 2020-11-16 | -$227.00K derived: sum of 4 quarters · filed 2020-11-16 |
| 2019-06-30 | -$56.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | -$113.00K 10-Q · filed 2020-08-12 | -$170.00K derived: sum of 3 quarters · filed 2020-08-12 | -$284.00K derived: sum of 4 quarters · filed 2020-08-12 |
| 2019-03-31 | -$57.00K 10-Q · filed 2020-05-15 | -$114.00K derived: sum of 2 quarters · filed 2020-05-15 | -$228.00K derived: sum of 3 quarters · filed 2020-05-15 | -$341.00K derived: sum of 4 quarters · filed 2020-05-15 |
| 2018-12-31 | -$57.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | -$171.00K derived: sum of 2 quarters · filed 2020-03-27 | -$284.00K derived: sum of 3 quarters · filed 2020-03-27 | -$398.00K 10-K · filed 2020-03-27 |
| 2018-09-30 | -$114.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$227.00K derived: sum of 2 quarters · filed 2019-11-12 | -$341.00K 10-Q · filed 2019-11-12 | |
| 2018-06-30 | -$113.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | -$227.00K 10-Q · filed 2019-08-14 | ||
| 2018-03-31 | -$114.00K 10-Q · filed 2019-05-15 | |||
| 2017-12-31 | -$454.00K 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |